Document:

EX-10.18

Exhibit 10.18

 

MERCK & CO., INC.

PLAN FOR DEFERRED PAYMENT OF

DIRECTORS’ COMPENSATION

(Amended and Restated as of January 1, 2009)

 

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 
	 	 	 	 	Page
	Article I	 	Purpose
	 	 	1	 
	 	 	 
	 	 	 	 
	Article II	 	Election of Deferral, Investment Alternatives and Distribution Schedule
	 	 	1	 
	 	 	 
	 	 	 	 
	Article III	 	Valuation of Deferred Amounts
	 	 	3	 
	 	 	 
	 	 	 	 
	Article IV	 	Redesignation Within a Deferral Account
	 	 	4	 
	 	 	 
	 	 	 	 
	Article V	 	Payment of Deferred Amounts
	 	 	5	 
	 	 	 
	 	 	 	 
	Article VI	 	Designation of Beneficiary
	 	 	5	 
	 	 	 
	 	 	 	 
	Article VII	 	Plan Amendment or Termination
	 	 	6	 
	 	 	 
	 	 	 	 
	Article VIII	 	Section 409A Compliance
	 	 	6	 

(i)

 

MERCK & CO., INC.

PLAN FOR DEFERRED PAYMENT OF

DIRECTORS’ COMPENSATION

I. PURPOSE

The Merck & Co., Inc. Plan for Deferred Payment of Directors’ Compensation (“Plan”)
provides an unfunded arrangement for directors of Merck & Co., Inc. other than current
employees to value, account for and ultimately distribute amounts deferred (i) voluntarily
in case of annual retainers and Board and committee meeting fees and (ii) mandatorily in
certain other cases as described herein.

			
	II.	 ELECTION OF DEFERRAL, INVESTMENT ALTERNATIVES AND DISTRIBUTION SCHEDULE

	 	A.	 	Election of Voluntary Deferral Amount
	 
	 	1.	 	Prior to December 31 of each year, each director may irrevocably elect (an
“Initial Election”) to defer, until termination of service as a director or later, 50%
or 100% of each of the following (together, the “Voluntary Deferral Amount”) with
respect to the 12 months beginning April 1 of the next calendar year after such
Initial Election:

(a) Board retainer

(b) Committee Chairperson retainer

(c) Audit Committee member retainer, and

(d) Board and committee meeting fees.

	 	2.	 	Prior to commencement of duties as a director or within the first 30 days
following commencement of services, a director newly elected or appointed to the Board
during a calendar year may make an Initial Election for the portion of the Voluntary
Deferral Amount applicable to such director’s first year of service (or part thereof).
	 
	 	3.	 	The Voluntary Deferral Amount shall be credited as follows: (1) Board and
committee meeting fees that are deferred are credited as of the last business day of
each calendar quarter; (2) if the Board retainer, Lead Director retainer, Committee
Chairperson retainer and/or Audit Committee member retainer are deferred, a pro-rata
share of the deferred retainer is credited as of the last business day of each
calendar quarter. The dates as of which the Voluntary Deferral Amount, or parts
thereof, are credited to the director’s deferred account are hereinafter referred to
as the Voluntary Deferral Dates.
	 
	 	4.	 	Effective December 1, 2008, once an Initial Election is made, it shall
continue to apply in successive years on the same terms and conditions until the
director makes a new Initial Election.
	 
	 	B.	 	Mandatory Deferral Amount
	 
	 	1.	 	As of the Friday following the Company’s Annual Meeting of Stockholders (the
“Mandatory Deferral Date”), each director will be credited with an amount equivalent
to the annual cash retainer for the 12 month period beginning on the

 

 

	 	 	 	April 1 preceding the Annual Meeting (the “Mandatory Deferral Amount”). The
Mandatory Deferral Amount will be measured by the Merck Common Stock account.

	 	2.	 	A director newly elected or appointed to the Board after the Mandatory
Deferral Date will be credited with a pro rata portion of the Mandatory Deferral
Amount applicable to such director’s first year of service (or part thereof). Such
pro rata portion shall be credited to the director’s account as of the first day of
such director’s service.
	 
	 	C.	 	Automatic Deferral of Executive Committee Fees
	 
	 	 	 	Between June 2005, and April 2007, directors who served as either Chairperson or
member of the Board’s Executive Committee, in lieu of any cash payment for such
service, were credited with an amount provided by way of retainer or meeting fees
(the “Automatic Deferral Amount”). The Automatic Deferral Amount is measured by
the Merck Common Stock account.
	 
	 	D.	 	Election of Investment Alternatives
	 
	 	 	 	Each Initial Election shall include an election as to the investment alternatives
by which the value of amounts deferred will be measured in accordance with Article
III, below. Investment alternatives available under this Plan shall be the same as
the investment alternatives available from time to time under the Merck & Co., Inc.
Deferral Program (the “Executive Deferral Program”); provided, however, that at all
times there shall be a Merck Common Stock fund. All investment alternatives other
than Merck Common Stock are referred to herein as “Other Investment Alternatives.”
	 
	 	E.	 	Initial Election of Distribution Schedule
	 
	 	 	 	An Initial Election shall include an election of the year during which the
Distribution Date (as defined below) shall occur and shall apply to all Voluntary
Deferral Amounts, Mandatory Deferral Amounts and Automatic Deferral Amounts
credited during the same period. The Distribution Date shall be the 15th day of
the month (or, if such day is not a business day, the next business day) of a
calendar quarter following the Director’s termination of service as a director or
such number of years thereafter as would be permitted for distributions elected
under the Executive Deferral Program.
	 
	 	F.	 	Changes to Distribution Schedule 
	 
	 	 	 	If and to the extent that participants in the Executive Deferral Program are
permitted to make re-deferral elections from time to time, participants in this
Plan may elect to defer their Distribution Dates subject to the same restrictions
applicable under the Executive Deferral Program; provided, however, that no
re-deferral election may have the effect of accelerating a distribution prior to a
director’s termination of service or death.

2

 

III. VALUATION OF DEFERRED AMOUNTS

	 	A.	 	Merck Common Stock
	 
	 	1.	 	Initial Crediting. The annual Mandatory Deferral Amount shall be used to
determine the number of full and partial shares of Merck Common Stock that such amount
would purchase at the closing price of the Common Stock on the New York Stock Exchange
(“NYSE”) on the Mandatory Deferral Date.
	 
	 	 	 	The Automatic Deferral Amount was used to determine the number of full and partial shares of Merck Common Stock that such amount would have purchased at the closing
price of the Common Stock on the NYSE.
	 
	 	 	 	That portion of the Voluntary Deferral Amount allocated to Merck Common Stock shall
be used to determine the number of full and partial shares of Merck Common Stock
that such amount would purchase at the closing price of the Common Stock on the
NYSE on the applicable Voluntary Deferral Date.
	 
	 	 	 	This Plan is unfunded: at no time will any shares of Merck Common Stock be
purchased or earmarked for such deferred amounts nor will any rights of a
shareholder exist with respect to such amounts.
	 
	 	2.	 	Dividends. Each director’s account will be credited with the additional
number of full and partial shares of Merck Common Stock that would have been
purchasable with the dividends on shares previously credited to the account at the
closing price of the Common Stock on the NYSE on the date each dividend was paid.
	 
	 	3.	 	Distributions. Distributions from the Merck Common Stock account will be
valued at the closing price of Merck Common Stock on the NYSE as of the Distribution
Date.
	 
	 	4.	 	For purposes of valuation of Merck Common Stock, if Merck Common Stock is no
longer traded on the NYSE, but is publicly traded on any other exchange, references to
NYSE shall mean such other exchange. If Merck Common Stock is not publicly traded and
if the Committee on Corporate Governance of the Board of Directors determines that a
measurement of Merck Common Stock on any Mandatory or Voluntary Deferral Date or
Distribution Date would not constitute fair market value, then the Committee shall
decide on the date and method to determine fair market value, which shall be in accord
with any requirements set forth under Section 409A or any successor thereto.
	 
	 	B.	 	Other Investment Alternatives
	 
	 	1.	 	Initial Crediting. The amount allocated to each Other Investment Alternative
shall be used to determine the full and partial Other Investment Alternative shares
that such amount would purchase at the closing net asset value of the Other Investment
Alternative shares on the Mandatory or Voluntary Deferral Date, whichever is
applicable. The director’s account will be credited with the number of full and
partial Other Investment Alternative shares so determined.

3

 

	 	 	 	At no time will any Other Investment Alternative shares be purchased or earmarked
for such deferred amounts nor will any rights of a shareholder exist with respect
to such amounts.

	 	2.	 	Dividends. Each director’s account will be credited with the additional
number of full and partial Other Investment Alternative shares that would have been
purchasable, at the closing net asset value of the Other Investment Alternative shares
as of the date each dividend is paid on the Other Investment Alternative shares, with
the dividends that would have been paid on the number of shares previously credited to
such account (including pro rata dividends on any partial shares).
	 
	 	3.	 	Distributions. Other Investment Alternative distributions will be valued
based on the closing net asset value of the Other Investment Alternative shares as of
the Distribution Date.
	 
	 	C.	 	Adjustments
	 
	 	 	 	In the event of a reorganization, recapitalization, stock split, stock dividend,
combination of shares, merger, consolidation, rights offering or any other change
in the corporate structure or shares of the Company or an Other Investment
Alternative, the number and kind of shares or units shall be adjusted accordingly.

IV. REDESIGNATION WITHIN A DEFERRAL ACCOUNT

	 	A.	 	General
	 
	 	 	 	A director may redesignate how his or her account is invested among the Other
Investment Alternatives (a “Redesignation”). A Redesignation affects only the
Investment Alternatives; it does not affect the timing of distributions from the
Plan. Amounts deferred using the Merck Common Stock method and any earnings
attributable to such deferrals may not be redesignated prior to the first
anniversary of the termination of the director’s service. The change will be
effective at the closing price as of (i) the day when the redesignation request is
received pursuant to administrative guidelines established by the Human Resources
Financial Services area provided the request is received prior to the close of the
NYSE on such day or (ii) the next following business day if the request is received
when the NYSE is closed.

	 	B.	 	When Redesignation May Occur
	 
	 	1.	 	During Active Service. There is no limit on the number of times a director
may Redesignate the portion of his/her deferred account permitted to be Redesignated.
Each such request shall be irrevocable and can be Redesignated in whole percentages or
as a dollar amount.
	 
	 	2.	 	After Death. Following the death of a director, the legal representative or
beneficiary of such director may Redesignate subject to the same rules as for active
directors set forth in Article IV, Section B.1.

4

 

	 	C.	 	Valuation of Amounts to be Redesignated 
	 
	 	 	 	The portion of the director’s account to be Redesignated will be valued at its cash
equivalent and such cash equivalent will be converted into shares or units of the
Other Investment Alternatives. For purposes of such Redesignations, the cash
equivalent of the value of the Other Investment Alternative shares shall be the
closing net asset value of such Other Investment Alternative as of (i) the day when
the Redesignation request is received pursuant to administrative guidelines
established by the Human Resources Financial Services area of the Treasury
department, provided the request is received prior to the close of the NYSE on such
day or (ii) the next following business day if the request is received when the
NYSE is closed.

V. PAYMENT OF DEFERRED AMOUNTS

	 	A.	 	Payment
	 
	 	 	 	All payments to directors of amounts deferred will be in cash as of the
Distribution Date. Distributions shall be pro rata by investment alternative.
Distributions shall be paid as soon as administratively feasible after the
Distribution Date.
	 
	 	B.	 	Forfeitures
	 
	 	 	 	A director’s deferred amount attributable to the Mandatory Deferral Amount and
earnings thereon shall be forfeited upon his or her removal as a director or upon a
determination by the Committee on Corporate Governance, in its sole discretion
that, a director has:

	 	(i)	 	joined the Board of, managed, operated, participated in a
material way in, entered employment with, performed consulting (or any other)
services for, or otherwise been connected in any material manner with a
company, corporation, enterprise, firm, limited partnership, partnership,
person, sole proprietorship or any other business entity determined by the
Committee on Corporate Governance in its sole discretion to be competitive
with the business of the Company, its subsidiaries or its affiliates (a
“Competitor”);
	 
	 	(ii)	 	directly or indirectly acquired an equity interest of
5 percent or greater in a Competitor; or
	 
	 	(iii)	 	disclosed any material trade secrets or other material
confidential information, including customer lists, relating to the Company or
to the business of the Company to others, including a Competitor.

VI. DESIGNATION OF BENEFICIARY

In the event of the death of a director:

A. The deferred amount at the date of death shall be paid to the last named beneficiary or
beneficiaries designated by the director, or, if no beneficiary has been designated, to the
legal representative of the director’s estate.

5

 

B. A lump sum distribution of any remaining account balance will be made to the director’s
beneficiary or estate’s legal representative as soon as administratively feasible following
such death, whether or not the director was in service at the time of death or has
commenced to receive payments of his or her account balance. The Distribution Date of such
a distribution shall be the 15th day of the month (or, if such day is not a business day,
the next business day) of the calendar quarter following the date the Company learns of
such death.

VII. PLAN AMENDMENT OR TERMINATION

The Committee on Corporate Governance shall have the right to amend or terminate this Plan
at any time for any reason.

VIII. SECTION 409A COMPLIANCE

Anything in the Plan to the contrary notwithstanding, the Plan shall comply with Section
409A of the Internal Revenue Code (or any successor thereto) and shall be interpreted in
accordance therewith. Any payment called for under the Plan as of or as soon as
administratively feasible on or after a designated date shall be made no later than a date
within the same tax year of a director, or by March 15 of the following year, if later (or
such other time as permitted in Treas. Reg. Sec. 1.409A-3(d) or any successor thereto);
provided further, that the director is not permitted to designate the taxable year of
payment. Where the Plan’s obligation to pay is unclear, including a dispute about who is
the proper beneficiary of a director who dies, payment shall be made as soon as
adminstratively feasible after the Program’s obligation becomes clear and at a time
permitted by Treas. Reg. Sec. 1.409A-3(g)(4) or any successor thereto.

6EX-10.40

 

Exhibit 10.40

AMENDED AND RESTATED

EMPLOYMENT AGREEMENT

          This AMENDED AND RESTATED EMPLOYMENT AGREEMENT is made and entered into as of this
1st day of October, 2008 by and between Allied World National Assurance Company, a New
Hampshire corporation (the “Company”), and W. Gordon Knight (“Employee”).

WITNESSETH:

          WHEREAS, the Company and Employee previously entered into an employment agreement as of
January 16, 2008 (the “Former Employment Agreement”) embodying the terms of Employee’s
employment; and

          WHEREAS, the Company and Employee desire to enter into a new agreement embodying the amended
and restated terms of Employee’s employment as set forth herein (this “Agreement”) and
agree that this Agreement shall supersede the Former Employment Agreement and that the Former
Employment Agreement shall be of no further force or effect;

          NOW, THEREFORE, in consideration of the promises and mutual covenants contained herein and for
other good and valuable consideration, the receipt and sufficiency of which are mutually
acknowledged, the Company and Employee hereby agree as follows:

          Section 1. Definitions.

          (a) “Accrued Obligations” shall mean (i) all accrued but unpaid Base Salary through
the date of termination of Employee’s employment; (ii) any unpaid or unreimbursed expenses incurred
in accordance with Company policy, including amounts due under Section 7 hereof, to the extent
incurred prior to termination of employment; (iii) any benefits provided under the Company’s
employee benefit plans upon a termination of employment, in accordance with the terms therein,
including rights to equity in Holdings pursuant to any plan or grant; and (iv) rights to
indemnification by virtue of Employee’s position as an officer or director of the Company or any
other member of the Company Group and the benefits under any directors’ and officers’ liability
insurance policy maintained by the Company, in accordance with its terms thereof.

          (b) “Agreement” shall have the meaning set forth in the recitals hereto.

          (c) “Annual Bonus” shall have the meaning set forth in Section 4(b) below.

          (d) “Base Salary” shall mean the salary provided for in Section 4(a) or any increased
salary granted to Employee pursuant to Section 4(a) below.

          (e) “Board” shall mean the Board of Directors of the Company.

          (f) “Cause” shall mean (i) Employee’s willful failure (except where due to physical or
mental incapacity), willful neglect or willful refusal to substantially perform his duties; (ii)
any willful or intentional act of Employee with regard to any member of the Company

 

 

Group that has the effect of injuring the reputation or business of any member of the Company
Group in a material manner; (iii) Employee’s conviction of, or plea of guilty or nolo
contendere to, the commission of a criminal act that would constitute a felony in the United
States; (iv) the commission by Employee of an act of fraud, embezzlement or material dishonesty
against any member of the Company Group (other than a good faith expense account dispute); or (v)
Employee’s breach of any material provision of this Agreement.

          (g) “Change in Control” shall mean and be deemed to occur if (i) any “person” (as
such term is defined in Section 3(a)(9) and as used in Sections 13(d) and 14(d) of the Exchange
Act), excluding any member of the Company Group, a trustee or any fiduciary holding securities
under an employee benefit plan of any member of the Company Group, an underwriter temporarily
holding Holdings’ securities pursuant to an offering of such securities or a corporation owned,
directly or indirectly, by shareholders of Holdings in substantially the same proportion as their
ownership of Holdings, is or becomes the “beneficial owner” as defined in Rule 13d-3 under the
Exchange Act, directly or indirectly, of securities of Holdings representing 50% or more of the
combined voting power of Holdings’ then outstanding securities (“Voting Securities”); (ii)
during any period of not more than two years, individuals who constitute the Board of Directors of
Holdings as of the beginning of the period and any new director (other than a director designated
by a person who has entered into an agreement with Holdings to effect a transaction described in
clause (i) or (iii) of this sentence) whose election by the Board of Directors of Holdings or
nomination for election by Holdings’ shareholders was approved by a vote of at least two-thirds
(2/3) of the directors then still in office who either were directors at such time or whose
election or nomination for election was previously so approved, cease for any reason to constitute
a majority thereof; (iii) the shareholders of Holdings approve a merger, consolidation,
amalgamation or reorganization or a court of competent jurisdiction approves a scheme of
arrangement of Holdings, other than a merger, consolidation, amalgamation, reorganization or scheme
of arrangement which would result in the Voting Securities of Holdings outstanding immediately
prior thereto continuing to represent (either by remaining outstanding or by being converted into
Voting Securities of the surviving entity) at least 50% of the combined voting power of the Voting
Securities of Holdings or such surviving entity outstanding immediately after such merger,
consolidation, amalgamation, reorganization or scheme of arrangement; or (iv) the shareholders of
Holdings approve a plan of complete liquidation of Holdings or any agreement for the sale or
disposition by Holdings of all or substantially all of its assets.

          (h) “Code” shall mean the United States Internal Revenue Code of 1986, as amended.

          (i) “Commencement Date” shall mean January 16, 2008.

          (j) “Company” shall have the meaning set forth in the preamble hereto.

          (k) “Company Group” means Holdings together with any direct or indirect subsidiary.

-2-

 

          (l) “Competitive Activities” shall mean any business activities in which any member of
the Company Group is engaged, or has committed plans to engage, during the Term of Employment.

          (m) “Confidential Information” shall have the meaning set forth in Section 9(a) below.

          (n) “Delay Period” shall have the meaning set forth in Section 16 below.

          (o) “Developments” shall have the meaning set forth in Section 9(e) below.

          (p) “Disability” shall mean any physical or mental disability or infirmity that has
prevented the performance of Employee’s duties in all material respects for a period of one hundred
eighty (180) consecutive calendar days.

          (q) “Employee” shall have the meaning set forth in the preamble hereto.

          (r) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

          (s) “Good Reason” shall mean, without Employee’s written consent, (i) an adverse
change in Employee’s employment title; (ii) a material diminution in Employee’s employment duties
or responsibilities, or the assignment to Employee of duties that are materially inconsistent with
his position; (iii) any reduction in Base Salary or target Annual Bonus opportunity; or (iv) any
breach by the Company of any material provision of this Agreement.

          (t) “Holdings” shall mean Allied World Assurance Company Holdings, Ltd, a Bermuda
corporation and the Company’s ultimate parent.

          (u) “Interfering Activities” shall mean (i) encouraging, soliciting or inducing, or in
any manner attempting to encourage, solicit or induce, any Person employed by, as agent of, or a
service provider to, any member of the Company Group to terminate (or, in the case of an agent or
service provider, reduce) such Person’s employment, agency or service, as the case may be, with any
member of the Company Group; provided, that the foregoing shall not be violated by general
advertising not targeted at employees of any member of the Company Group nor by serving as a
reference upon an employee’s request with regard to an entity with which Employee is not
affiliated; or (ii) encouraging, soliciting or inducing, or in any manner attempting to encourage,
solicit or induce any customer, supplier (including insurance brokers), licensee or other business
relation of any member of the Company Group to cease doing business with or reduce the amount of
business conducted with any member of the Company Group, or in any way interfere with the
relationship between any such customer, supplier (including insurance brokers), licensee or
business relation and any member of the Company Group.

          (v) “Person” shall mean any individual, corporation, partnership, limited liability
company, joint venture, association, joint-stock company, trust (charitable or non-charitable),
unincorporated organization or other form of business entity.

-3-

 

          (w) “Non-Interference Period” shall mean the period commencing on the Commencement
Date and ending on the twenty-four (24) month anniversary of the date of termination.

          (x) “Non-Compete Period” shall mean the period commencing on the Commencement Date
and:

          (i) in the case of Employee’s termination of employment hereunder by the Company for
Cause, ending on the date of such termination;

          (ii) in the case of Employee’s termination of employment hereunder by the Company
without Cause or by Employee for Good Reason, ending on the twenty-four (24) month
anniversary of the date of such termination; or

          (iii) in the case of Employee’s termination of employment hereunder by the Employee
without Good Reason or as a result of his Disability, ending on the date of such
termination; provided, however, that the Company may elect to extend the Non-Compete Period
up to an additional twelve (12) months following the date of such termination by providing
Employee written notice of such election within five (5) business days following such
termination specifying the applicable period of extension, in which case, the Company shall
be required to continue, through the end of the Non-Compete Period, as so extended, (A) to
pay Employee his Base Salary, in accordance with the Company’s regular payroll practices,
and (B) to provide participation under the Company’s health and other insurance plans, or if
such continued participation in is not permissible, provide Employee with coverage that is
economically equivalent to Employee through alternative arrangements, or the cash value of
such coverage, in a manner that places the Employee in a net economic position that is at
least equivalent to the position in which the Employee would have been had such alternative
arrangements not been used by the Company; provided, however, that if the cash value is paid
to Employee, it shall be paid to Employee no later than the date that is one day prior to
two and one-half months following the end of the Company’s fiscal year in which such
termination occurs.

          (y) “Release Expiration Date” shall have the meaning set forth in Section 8(g) below.

          (z) “Severance Multiplier” shall mean an amount equal to two (2); provided, however,
if Employee’s termination occurs within the twelve (12) month period following a Change in Control
the Severance Multiplier shall equal five (5) in the first twelve (12) month period following the
Commencement Date; four (4) in the second twelve (12) month period following the Commencement Date
and three (3) thereafter.

          (aa) “Severance Term” shall mean the period specified in Section 8(d)(iii) below.

          (bb) “Term of Employment” shall mean the period specified in Section 2 below.

-4-

 

          Section 2. Acceptance and Term of Employment.

          The Company agrees to employ Employee and Employee agrees to serve the Company on the terms
and conditions set forth herein. The Term of Employment shall commence on the Commencement Date
and shall continue until Employee is terminated as provided in Section 8 hereof.

          Section 3. Position, Duties and Responsibilities; Place of Performance.

          (a) During the Term of Employment, Employee shall be employed and serve as President of the
Company (together with such other position or positions consistent with Employee’s title as the
Board or the officer of the Company to which Employee reports shall specify from time to time) and
shall have such duties typically associated with such title. Subject to the foregoing, Employee
also agrees to serve as an officer and/or director of any other member of the Company Group, in
each case without additional compensation. Notwithstanding anything contained herein to the
contrary, in connection with any restructuring of the Company Group, the Company shall be permitted
to transfer Employee’s employment to any other member of the Company Group without such transfer in
and of itself resulting in an event pursuant to which Employee may terminate employment with Good
Reason.

          (b) Subject to the terms and conditions set forth in this Agreement, Employee shall devote his
full business time, attention and efforts to the performance of his duties under this Agreement and
shall not engage in any other business or occupation during the Term of Employment, including,
without limitation, any activity that (x) conflicts with the interests of any member of the Company
Group, (y) interferes with the proper and efficient performance of his duties for the Company or
(z) interferes with the exercise of his judgment in the Company’s best interests. Notwithstanding
the foregoing, nothing herein shall preclude Employee from (i) serving, with the prior written
consent of the Company, as a member of the board of directors or advisory boards (or their
equivalents in the case of a non-corporate entity) of non-competing businesses and charitable
organizations, (ii) engaging in charitable activities and community affairs, and (iii) subject to
the terms and conditions set forth in Section 9 hereof, managing his personal investments and
affairs; provided, however, that the activities set out in clauses (i), (ii) and (iii) shall be
limited by Employee so as not to materially interfere, individually or in the aggregate, with the
performance of his duties and responsibilities hereunder.

          (c) Employee’s principal place of employment shall be at the Company’s New York office,
although Employee understands and agrees that he may be required to travel from time to time for
business reasons.

          Section 4. Compensation.

          During the Term of Employment, Employee shall be entitled to the following compensation:

          (a) Base Salary. Employee shall be paid an annualized Base Salary, payable in
accordance with the regular payroll practices of the Company, of not less than $525,000, subject to
increase, if any, as may be approved in writing by the Company, but not to decrease from the then
current Base Salary.

-5-

 

          (b) Annual Bonus. Employee shall be eligible for an annual incentive bonus award
determined by the Company in respect of each fiscal year during the Term of Employment (the
“Annual Bonus”). The Annual Bonus shall be earned and payable in accordance with the terms
of Holdings’ annual bonus plan as in effect from time to time.

          (c) Change in Control Acceleration. Notwithstanding any contrary terms of any
Holdings equity plan or other agreement pursuant to which equity-based awards have been granted to
Employee, upon the occurrence of a Change in Control, all such equity-based awards shall fully vest
immediately prior to such Change in Control.

          Section 5. Employee Benefits.

          During the Term of Employment, Employee shall be entitled to participate in health, insurance,
retirement and other perquisites and benefits generally provided to other senior executives of the
Company that are made available and as are in effect from time to time. Employee shall also be
entitled to the same number of holidays, vacation and sick days as are generally allowed to senior
executives of the Company in accordance with the Company policy in effect from time to time.
During the Term of Employment, Employee shall also be entitled to reimbursement or payment of the
cost of financial and tax planning, such reimbursement not to exceed $10,000 per year.

          Section 6. “Key-Man” Insurance.

          At any time during the Term of Employment, the Company shall have the right to insure the life
of Employee for the sole benefit of the Company, in such amounts, and with such terms, as it may
determine. All premiums payable thereon shall be the obligation of the Company. Employee shall
have no interest in any such policy, but agrees to reasonably cooperate with the Company in taking
out such insurance by submitting to physical examinations, supplying all information reasonably
required by the insurance company, and executing all necessary documents, provided that no
financial obligation or liability is imposed on Employee by any such documents.

          Section 7. Reimbursement of Business Expenses.

          Employee is authorized to incur reasonable business expenses in carrying out his duties and
responsibilities under this Agreement and the Company shall promptly reimburse him for all such
reasonable business expenses incurred in connection with carrying out the business of the Company,
subject to documentation in accordance with the Company’s policy, as in effect from time to time.

          Section 8. Termination of Employment.

          (a) General. The Term of Employment shall terminate upon the earliest to occur of (i)
Employee’s death, (ii) a termination by reason of a Disability, (iii) a termination by the Company
with or without Cause, and (iv) a termination by Employee with or without Good Reason. Upon any
termination of Employee’s employment for any reason, except as may otherwise be requested by the
Company in writing and agreed upon in writing by Employee,

-6-

 

Employee shall resign from any and all directorships, committee memberships or any other
positions Employee holds with any member of the Company Group.

          (b) Termination due to Death or Disability. Employee’s employment shall terminate
automatically upon his death. The Company may terminate Employee’s employment immediately upon the
occurrence of a Disability, such termination to be effective upon Employee’s receipt of written
notice of such termination. In the event Employee’s employment is terminated due to his death or
Disability, Employee or his estate or his beneficiaries, as the case may be, shall be entitled to:

          (i) The Accrued Obligations;

          (ii) Any unpaid Annual Bonus in respect to any completed fiscal year which has ended
prior to the date of such termination, such amount to be paid at the same time it would
otherwise be paid to Employee had no such termination occurred, but in no event later than
the date that is one day prior to two and one-half months following the end of the Company’s
fiscal year in which such termination occurs;

          (iii) A pro rata Annual Bonus (determined using the target Annual Bonus if such
termination occurs during the fiscal year in which the Commencement Date falls, and using
the highest Annual Bonus paid or payable for the two immediately prior fiscal years for
terminations after the fiscal year in which the Commencement Date falls) based on the number
of days elapsed from the commencement of such fiscal year through and including the date of
such termination, such amount to be paid within five (5) business days of such termination;
and

          (iv) Vesting, as of the date of such termination, in the number of equity-based awards,
if any, which would otherwise have vested during the one (1) year period immediately
following such termination (without regard to any subsequent vesting events).

Except as set forth in this Section 8(b), following Employee’s termination by reason of his death
or Disability, Employee shall have no further rights to any compensation or any other benefits
under this Agreement.

          (c) Termination by the Company for Cause.

          (i) A termination for Cause shall not take effect unless the provisions of this
subsection (i) are complied with. Employee shall be given not less than fifteen (15) days
prior written notice by the Company of the intention to terminate his employment for Cause,
such notice to state in detail the particular act or acts or failure or failures to act that
constitute the grounds on which the proposed termination for Cause is based. Employee shall
have fifteen (15) days after the date that such written notice has been given to Employee in
which to cure such act or acts or failure or failures to act, to the extent such cure is
possible. If he fails to cure such act or acts or failure or failures to act, the
termination shall be effective on the date immediately following the expiration of the
fifteen (15) day notice period. If cure is not possible, the termination shall be effective
on the date of receipt of such notice by Employee. During any cure period

-7-

 

provided hereunder, the Company may, in its sole and absolute discretion, prohibit
Employee from entering the premises of any member of the Company Group or otherwise
performing his duties hereunder, and any such prohibition shall in no event constitute an
event pursuant to which Employee may terminate employment with Good Reason; provided,
however, that if cure is possible, and Employee can reasonably demonstrate to the Company
that he desires to enter the premises of any member of the Company Group or to otherwise
perform his duties hereunder solely to attempt to cure the act or acts or failure or
failures to act that constitute the grounds on which the proposed termination for Cause is
based, Employee shall be permitted to enter the premises of any member of the Company Group
or otherwise to perform his duties hereunder solely for the purposes of curing such act or
acts or failure or failures to act.

          (ii) In the event the Company terminates Employee’s employment for Cause, he shall be
entitled only to the Accrued Obligations. Following such termination of Employee’s
employment for Cause, except as set forth in this Section 8(c)(ii), Employee shall have no
further rights to any compensation or any other benefits under this Agreement.

          (d) Termination by the Company without Cause. The Company may terminate Employee’s
employment at any time without Cause, effective upon Employee’s receipt of written notice of such
termination. In the event Employee’s employment is terminated by the Company without Cause (other
than due to death or Disability), Employee shall be entitled to:

          (i) The Accrued Obligations;

          (ii) Any unpaid Annual Bonus in respect to any completed fiscal year which has ended
prior to the date of such termination, such amount to be paid at the same time it would
otherwise be paid to Employee had no such termination occurred, but in no event later than
the date that is one day prior to two and one-half months following the end of the Company’s
fiscal year in which such termination occurs;

          (iii) An amount equal to the Severance Multiplier multiplied by the sum of his then
current Base Salary and Annual Bonus (determined using the target Annual Bonus if such
termination occurs during the fiscal year in which the Commencement Date falls, and using
the highest Annual Bonus paid or payable for the two immediately prior fiscal years for
terminations after the fiscal year in which the Commencement Date falls), payable in
substantially equal monthly installments over the period commencing on the date of
termination and ending on the date that is one day prior to two and one-half months
following the end of the Company’s fiscal year in which such termination occurs (the
“Severance Term”);

          (iv) Continuation of participation under the Company’s health and other insurance plans
for a period of years equal to the Severance Multiplier, or if such continued participation
in is not permissible, provide Employee with coverage that is economically equivalent to
Employee through alternative arrangements, or the cash value of such coverage, in a manner
that places the Employee in a net economic position that is at least equivalent to the
position in which the Employee would have been had such

-8-

 

alternative arrangements not been used by the Company; provided, however, that if the
cash value is paid to Employee, it shall be paid to Employee no later than the date that is
one day prior to two and one-half months following the end of the Company’s fiscal year in
which such termination occurs; and

          (v) Vesting, as of the date of such termination, in the number of equity-based awards,
if any, which would otherwise have vested during the two (2) year period immediately
following such termination (without regard to any subsequent vesting events).

Notwithstanding the foregoing, the payments and benefits described in subsections (ii) through (iv)
above shall immediately cease, and the Company shall have no further obligations to Employee with
respect thereto, in the event that Employee breaches any provision of Section 9 hereof.

          Following such termination of Employee’s employment by the Company without Cause, except as
set forth in this Section 8(d), Employee shall have no further rights to any compensation or any
other benefits under this Agreement.

          (e) Termination by Employee with Good Reason. Employee may terminate his employment
with Good Reason by providing the Company fifteen (15) days prior written notice setting forth in
reasonable specificity the event that constitutes Good Reason, which written notice, to be
effective, must be provided to the Company within ninety (90) days of the occurrence of such event.
During such fifteen (15) day notice period, the Company shall have a cure right (if curable), and
if not cured within such period, Employee’s termination will be effective upon the date immediately
following the expiration of the fifteen (15) day notice period, and Employee shall be entitled to
the same payments and benefits as provided in Section 8(d) above for a termination without Cause,
it being agreed that Employee’s right to any such payments and benefits shall be subject to the
same terms and conditions as described in Section 8(d) above. Following such termination of
Employee’s employment by Employee with Good Reason, except as set forth in this Section 8(e),
Employee shall have no further rights to any compensation or any other benefits under this
Agreement.

          (f) Termination by Employee without Good Reason. Employee may terminate his
employment without Good Reason by providing the Company thirty (30) days prior written notice of
such termination. In the event of a termination of employment by Employee under this Section 8(f),
Employee shall be entitled only to the Accrued Obligations. In the event of termination of
Employee’s employment under this Section 8(f), the Company may, in its sole and absolute
discretion, by written notice accelerate such date of termination and still have it treated as a
termination without Good Reason. Following such termination of Employee’s employment by Employee
without Good Reason, except as set forth in this Section 8(f), and, if applicable, such additional
compensation and benefits described in Section 1(x)(iii), Employee shall have no further rights to
any compensation or any other benefits under this Agreement.

          (g) Release. Notwithstanding any provision herein to the contrary, the Company may
require that, prior to payment of any amount or provision of any benefit pursuant

-9-

 

to subsections (d) or (e) of this Section 8, Employee shall have executed a general release in
favor of the Company and any other member of the Company Group and related parties in the form as
is reasonably required by the Company, and any waiting periods contained in such release shall have
expired. Such release, if required by the Company, shall be delivered to Employee within twenty
(20) business days following the termination of Employee’s employment hereunder, and failure to
deliver such release within such twenty (20) business day period shall be deemed to constitute a
waiver of such requirement. Assuming delivery of the release by the Company, if Employee fails to
execute such release on or prior to the Release Expiration Date, Employee shall not be entitled to
any payments or benefits pursuant to (d) or (e) of this Section 8 (other than the Accrued
Obligations). Notwithstanding anything contained in this subsection (g) to the contrary, in any
case where the date of termination and the last day of the applicable waiting period fall in two
separate taxable years, any payments required to be made to Employee that are treated as deferred
compensation for purposes of Section 409A of the Code shall be made in the later taxable year at
times provided by this Section 8. For purposes of this Agreement, “Release Expiration
Date” means the date which is twenty-one (21) days following the date upon which the Company
delivers to Employee the release contemplated herein, or in the event that such termination of
employment is “in connection with an exit incentive or other employment termination program” (as
such phrase is defined in the Age Discrimination in Employment Act of 1967), the date that is
forty-five (45) days following such delivery date.

          Section 9. Restrictive Covenants.

          Employee acknowledges and agrees that (A) the agreements and covenants contained in this
Section 9 are (i) reasonable and valid in geographical and temporal scope and in all other
respects, and (ii) essential to protect the value of the business and assets of the Company Group;
and (B) by his employment with the Company, Employee will obtain knowledge, contacts, know-how,
training and experience and there is a substantial probability that such knowledge, contacts,
know-how, training and experience could be used to the substantial advantage of a competitor of the
Company Group and to the Company Group’s substantial detriment.

          (a) Confidential Information. At any time during and after the end of the Term of
Employment, without the prior written consent of the Company, except to the extent required by an
order of a court having jurisdiction or under subpoena from an appropriate government agency, in
which event, Employee shall, to the extent legally permitted, consult with the Company prior to
responding to any such order or subpoena, and except as he in good faith believes necessary or
desirable in the performance of his duties hereunder, Employee shall not disclose to or use for the
benefit of any third party any confidential or proprietary trade secrets, customer lists, drawings,
designs, information regarding product development (including types of insurance products),
marketing plans, sales plans, management organization information, operating policies (including
underwriting policies and risk assessment policies) or manuals, business plans, financial records,
packaging design or other financial, commercial, business or technical information (i) relating to
any member of the Company Group, or (ii) that any member of the Company Group may receive belonging
to suppliers, customers or others who do business with any member of the Company Group (including
insurance brokers) as a result of his position with any member of the Company Group (collectively,
“Confidential Information”).

-10-

 

Employee’s obligation under this Section 9(a) shall not apply to any information that is
publicly available or hereafter becomes publicly available, in each case without the breach by
Employee of this Section 9(a).

          (b) Non-Competition. Employee covenants and agrees that during the Non-Compete
Period, with respect to Bermuda (including any province thereof), any State of the United States of
America or any other jurisdiction in which any member of the Company Group engages (or has
committed plans to engage) in business during the Term of Employment, or, following termination of
Employee’s employment, was engaged in business (or had committed plans to engage) at the time of
such termination of employment, Employee shall not, directly or indirectly, individually or
jointly, own any interest in, operate, join, control or participate as a partner, director,
principal, officer, or agent of, enter into the employment of, act as a consultant to, or perform
any services for any Person (other than any member of the Company Group), that engages in any
Competitive Activities. Notwithstanding anything herein to the contrary, this Section 9(b) shall
not prevent Employee from acquiring as an investment securities representing not more than three
percent (3%) of the outstanding voting securities of any publicly-held corporation or from being a
passive investor in any mutual fund, hedge fund, private equity fund or similar pooled account so
long as Employee’s interest therein is less than three percent (3%) and he has no role in selecting
or managing investments thereof.

          (c) Non-Interference. During the Non-Interference Period, Employee shall not,
directly or indirectly, for his own account or for the account of any other Person, engage in
Interfering Activities.

          (d) Return of Documents. In the event of the termination of Employee’s employment for
any reason, Employee shall deliver to the Company all of (i) the property of any member of the
Company Group, and (ii) the documents and data of any nature and in whatever medium of any member
of the Company Group, and he shall not take with him any such property, documents or data or any
reproduction thereof, or any documents containing or pertaining to any Confidential Information.

          (e) Works for Hire. Employee agrees that the Company shall own all right, title and
interest throughout the world in and to any and all inventions, original works of authorship,
developments, concepts, know-how, improvements or trade secrets, whether or not patentable or
registerable under copyright or similar laws, which Employee may solely or jointly conceive or
develop or reduce to practice, or cause to be conceived or developed or reduced to practice during
the Term of Employment, whether or not during regular working hours, provided they either (i)
relate at the time of conception or development to the actual or demonstrably proposed business or
research and development activities of any member of the Company Group; (ii) result from or relate
to any work performed for any member of the Company Group; or (iii) are developed through the use
of Confidential Information and/or Company resources or in consultation with personnel of any
member of the Company Group (collectively referred to as “Developments”). Employee hereby
assigns all right, title and interest in and to any and all of these Developments to the Company.
Employee agrees to assist the Company, at the Company’s expense (but for no other consideration of
any kind), to further evidence, record and perfect such assignments, and to perfect, obtain,
maintain, enforce and defend any rights specified to be so owned or assigned. Employee hereby
irrevocably designates and appoints the Company and its

-11-

 

agents as attorneys-in-fact to act for and on Employee’s behalf to execute and file any
document and to do all other lawfully permitted acts to further the purposes of the foregoing with
the same legal force and effect as if executed by Employee. In addition, and not in contravention
of any of the foregoing, Employee acknowledges that all original works of authorship which are made
by him (solely or jointly with others) within the scope of employment and which are protectable by
copyright are “works made for hire,” as that term is defined in the United States Copyright Act (17
USC Sec. 101) or any similar law or regulation. To the extent allowed by law, this includes all
rights of paternity, integrity, disclosure and withdrawal and any other rights that may be known as
or referred to as “moral rights.” To the extent Employee retains any such moral rights under
applicable law, Employee hereby waives such moral rights and consents to any action consistent with
the terms of this Agreement with respect to such moral rights, in each case, to the full extent of
such applicable law. Employee will confirm any such waivers and consents from time to time as
requested by the Company.

          (f) Blue Pencil. If any court of competent jurisdiction shall at any time deem the
duration or the geographic scope of any of the provisions of this Section 9 unenforceable, the
other provisions of this Section 9 shall nevertheless stand and the duration and/or geographic
scope set forth herein shall be deemed to be the longest period and/or greatest size permissible by
law under the circumstances, and the parties hereto agree that such court shall reduce the time
period and/or geographic scope to a permissible duration or size.

          Section 10. Breach of Restrictive Covenants.

          Without limiting the remedies available to the Company, Employee acknowledges that a breach of
any of the covenants contained in Section 9 hereof may result in material irreparable injury to the
Company Group for which there is no adequate remedy at law, that it will not be possible to measure
damages for such injuries precisely and that, in the event of such a breach or threat thereof, the
Company shall be entitled to obtain a temporary restraining order and/or a preliminary or permanent
injunction, without the posting of a bond or the necessity of proving irreparable harm or injury as
a result of such breach or threatened breach of Section 9 hereof, restraining Employee from
engaging in activities prohibited by Section 9 hereof or such other relief as may be required
specifically to enforce any of the covenants in Section 9 hereof. Notwithstanding any other
provision to the contrary, the Non-Compete Period, in the case of the covenants contained in
Section 9(b), and the Non-Interference Period, in the case of the covenants contained in Section
9(c), shall be tolled during any period of violation of any of such covenants and during any other
period required for litigation during which the Company seeks to enforce such covenants against
Employee or another Person with whom Employee is affiliated if it is ultimately determined that
Employee was in breach of such covenants.

          Section 11. Representations and Warranties of Employee.

          Employee represents and warrants to the Company that:

          (a) Employee’s employment will not conflict with or result in his breach of any agreement to
which he is a party or otherwise may be bound;

-12-

 

          (b) Employee has not violated, and in connection with his employment with the Company will not
violate, any non-solicitation, non-competition or other similar covenant or agreement of a prior
employer by which he is or may be bound; and

          (c) In connection with Employee’s employment with the Company, he will not use any
confidential or proprietary information that he may have obtained in connection with employment
with any prior employer.

          Section 12. Indemnification.

          Subject to the terms and conditions of the Articles or Certificate of Incorporation and Bylaws
of the Company (in each case, as in effect from time to time), the Company agrees to indemnify and
hold Employee harmless to the fullest extent permitted by the laws of the United States, as in
effect at the time of the subject act or omission. In connection therewith, Employee shall be
entitled to the protection of any insurance policies which the Company elects to maintain generally
for the benefit of the Company’s directors and officers, against all costs, charges and expenses
whatsoever incurred or sustained by Employee in connection with any action, suit or proceeding to
which he may be made a party by reason of his being or having been a director, officer or employee
of the Company. This provision shall survive any termination of Employee’s employment hereunder.

          Section 13. Taxes.

          The Company may withhold from any payments made under this Agreement all applicable taxes,
including, but not limited to, income, employment and social insurance taxes, as shall be required
by law.

          Section 14. No Mitigation or Set Off.

          Employee shall not be required to mitigate the amount of any payment provided for pursuant to
this Agreement by seeking other employment or otherwise and the amount of any payment provided for
pursuant to this Agreement shall not be reduced by any compensation earned as a result of
Employee’s other employment or otherwise.

          Section 15. Successors and Assigns; No Third-Party Beneficiaries.

          (a) The Company. This Agreement shall inure to the benefit of and be enforceable by,
and may be assigned by the Company to, any purchaser of all or substantially all of Holdings’ or
the Company’s business or assets or any successor to Holdings or the Company (whether direct or
indirect, by purchase, merger, consolidation or otherwise). Holdings or the Company will require,
as applicable, in a writing delivered to Employee, any such purchaser, successor or assignee to
expressly assume and agree to perform this Agreement in the same manner and to the same extent that
Holdings and the Company would be required to perform it if no such purchase, succession or
assignment had taken place. The Company may make no other assignment of this Agreement or its
obligations hereunder.

          (b) Employee. Employee’s rights and obligations under this Agreement shall not be
transferable by Employee by assignment or otherwise, without the prior written consent of

-13-

 

the Company; provided, however, that if Employee shall die, all amounts then payable to
Employee hereunder shall be paid in accordance with the terms of this Agreement to Employee’s
devisee, legatee or other designee or, if there be no such designee, to Employee’s estate.

          (c) No Third-Party Beneficiaries. Except as otherwise set forth in Section 8(b) or
Section 15(b) hereof, nothing expressed or referred to in this Agreement will be construed to give
any Person other than the Company and Employee any legal or equitable right, remedy or claim under
or with respect to this Agreement or any provision of this Agreement.

          Section 16. Delay in Payment.

          Notwithstanding any provision in this Agreement to the contrary, but taking into account
Treas. Reg. 1.409A-1(b)(9)(iii), any payment of nonqualified deferred compensation otherwise
required to be made hereunder to Employee at any date as a result of the termination of Employee’s
employment shall be delayed for such period of time as may be necessary to meet the requirements of
Section 409A(a)(2)(B)(i) of the Code (the “Delay Period”). On the earliest date on which
such payments can be made after the Delay Period, there shall be paid to the Employee, in a single
cash lump sum, an amount equal to the aggregate amount of all payments delayed pursuant to the
preceding sentence. Notwithstanding the foregoing, to the extent that the first sentence applies
to the provision of any ongoing health and other insurance plan benefits, Employee shall pay the
full cost for such health and other insurance plan benefits during the Delay Period and the Company
shall pay Employee an amount equal to the amount of such premiums paid by Employee during the Delay
Period within ten (10) days after the end of the Delay Period.

          Section 17. Waiver and Amendments.

          Any waiver, alteration, amendment or modification of any of the terms of this Agreement shall
be valid only if made in writing and signed by each of the parties hereto. No waiver by either of
the parties hereto of their rights hereunder shall be deemed to constitute a waiver with respect to
any subsequent occurrences or transactions hereunder unless such waiver specifically states that it
is to be construed as a continuing waiver.

          Section 18. Severability.

          If any covenants or such other provisions of this Agreement are found to be invalid or
unenforceable by a final determination of a court of competent jurisdiction: (a) the remaining
terms and provisions hereof shall be unimpaired, and (b) the invalid or unenforceable term or
provision hereof shall be deemed replaced by a term or provision that is valid and enforceable and
that comes closest to expressing the intention of the invalid or unenforceable term or provision
hereof.

          Section 19. Governing Law.

          THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
NEW YORK (WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES THEREOF) APPLICABLE TO CONTRACTS
MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE.

-14-

 

          Section 20. Dispute Resolution.

          Any controversy arising out of or relating to this Agreement or the breach hereof (other than
claims for injunctive relief pursuant to Section 10 hereof) shall be settled by binding arbitration
in accordance with the Employment Dispute Resolution Rules of the American Arbitration Association
(before a single arbitrator) and judgment upon the award rendered may be entered in any court
having jurisdiction thereof. The costs of any such arbitration proceedings shall be borne equally
by the Company and Employee; provided, however, that the arbitrator shall have the right to award
to either party reasonable attorneys’ fees and costs expended in the course of such arbitration or
enforcement of the awarded rendered thereunder. Any award made by such arbitrator shall be final,
binding and conclusive on the parties for all purposes, and judgment upon the award rendered by the
arbitrators may be entered in any court having jurisdiction thereof.

          Section 21. Notices.

          (a) Every notice or other communication relating to this Agreement shall be in writing, and
shall be mailed to or delivered to the party for whom it is intended at such address as may from
time to time be designated by it in a notice mailed or delivered to the other party as herein
provided, provided that, unless and until some other address be so designated, all notices or
communications by Employee to the Company shall be mailed or delivered to the Company at its
principal executive office, with a copy sent to the General Counsel of Holdings, and all notices or
communications by the Company to Employee may be given to Employee personally or may be mailed to
Employee at Employee’s last known address, as reflected in the Company’s records.

          (b) Any notice so addressed shall be deemed to be given: (i) if delivered by hand, on the
date of such delivery; (ii) if mailed by courier or by overnight mail, on the first business day
following the date of such mailing; and (iii) if mailed by registered or certified mail, on the
third business day after the date of such mailing.

          Section 22. Section Headings.

          The headings of the sections and subsections of this Agreement are inserted for convenience
only and shall not be deemed to constitute a part thereof, affect the meaning or interpretation of
this Agreement or of any term or provision hereof.

          Section 23. Entire Agreement.

          This Agreement constitutes the entire understanding and agreement of the parties hereto
regarding the employment of Employee. This Agreement supersedes all prior negotiations,
discussions, correspondence, communications, understandings and agreements between the parties
relating to the subject matter of this Agreement.

-15-

 

          Section 24. Survival of Operative Sections.

          Upon any termination of Employee’s employment, the provisions of Section 8 through Section 26
of this Agreement (together with any related definitions set forth in Section 1 hereof) shall
survive to the extent necessary to give effect to the provisions thereof.

          Section 25. Currency.

          All sums of money expressed in this Agreement are in the lawful money of the United States of
America.

          Section 26. Counterparts.

          This Agreement may be executed in two or more counterparts, each of which shall be deemed to
be an original but all of which together shall constitute one and the same instrument. The
execution of this Agreement may be by actual or facsimile signature.

[Signatures to appear on the following page.]

-16-

 

          IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above
written.

	 	 	 	 	 	 	 
	 	 	ALLIED WORLD NATIONAL ASSURANCE COMPANY	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Scott A. Carmilani	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Scott A. Carmilani	 	 
	 	 	Title: Director	 	 
	 
	 	 	 	 	 	 
	 	 	EMPLOYEE	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ W. Gordon Knight
 

W. Gordon Knight
	 	 

-17-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}]]